Table 6. Gynecological cancer summary (N = 2).

Study name (year)	Study type/size	HALP threshold (method)	Outcome(s)	Summary
Predictive Value of the Hemoglobin- Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients; Leetanaporn et al., (2022)	Retrospective N = 1588	22.2 (X-Tile)	OS and PFS in locally advanced cervical cancer patients undergoing RT and CCRT.	Patients with HALP scores <22.2 were associated with younger age, higher stage and tumor size in addition to being independently associated with worse PFS and OS.
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis; Njoku et al., (2022)	Prospective N = 439	24 (Compiled based on various other studies)	OS, PFS, and CSS in endometrial cancer patients.	HALP scores were not shown to be associated with overall, cancer-specific or recurrence-free survival.